A Metronidazole Metabolite in Human Urine and Its Risk
- 23 January 1981
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 211 (4480) , 398-400
- https://doi.org/10.1126/science.7221546
Abstract
Metronidazole is a drug used for the treatment of trichomonal vaginitis, amebiasis, giardiasis, and certain anaerobic bacterial infections in humans. Acetamide and N-(2-hydroxyethyl)oxamic acid are metabolites of metronidazole in the rat, and we find small amounts of both metabolites in the urine of human patients taking the drug. Although acetamide is carcinogenic for rats, we do not believe that our finding further defines metronidazole's risk for humans. That risk can only be estimated from surveillance of people previously exposed to the drug.This publication has 11 references indexed in Scilit:
- Case 42-1979: Systemic Lupus ErythematosusNew England Journal of Medicine, 1980
- Cancer after MetronidazoleNew England Journal of Medicine, 1980
- Acetamide—a metabolite of metronidazole formed by the intestinal floraBiochemical Pharmacology, 1979
- Lack of Evidence for Cancer Due to Use of MetronidazoleNew England Journal of Medicine, 1979
- Experimental Induction of Hepatomas, Mammary Tumors, and Other Tumors With Metronidazole in Noninbred Sas:MRC(WI)BR Rats2JNCI Journal of the National Cancer Institute, 1979
- ANAEROBIC METABOLISM OF METRONIDAZOLE FORMS N-(2-HYDROXYETHYL)-OXAMIC ACID1979
- Mutagenicity of metronidazole: Activation by mammalian liver microsomesBiochemical and Biophysical Research Communications, 1975
- Detection of Mutagenic Activity of Metronidazole and Niridazole in Body Fluids of Humans and MiceScience, 1975
- Prevention by arginine glutamate of the carcinogenicity of acetamide in ratsToxicology and Applied Pharmacology, 1969
- LIVER TUMORS IN RATS FED ACETAMIDE1961